Physician profile
Adrian Tenorio
NPI 1174632335
$3,167.61
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $206 · 2021: $282 · 2022: $1,414 · 2023: $258 · 2024: $306 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Entertainment: $83.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.12 |
| Entertainment | $83.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,355.66 | 2019-2025 | Dailies, Precision 1, Precision 7 |
| Aerie Pharmaceuticals, INC. | $222.05 | 2019-2021 | |
| Biotissue Holdings INC. | $209.80 | 2022-2025 | |
| Dompe US, INC. | $187.07 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $160.91 | 2019-2021 | |
| Notal Vision, INC. | $136.87 | 2022 | |
| Glaukos Corporation | $134.80 | 2022-2024 | Ce-Marked Kxla System |
| Rxsight INC | $131.12 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Shire North American Group INC | $124.55 | 2019 | |
| Allergan, INC. | $122.62 | 2020-2021 | |
| Optos, INC. | $83.70 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $61.41 | 2019 | |
| Sun Pharmaceutical Industries INC. | $59.72 | 2019-2025 | |
| Oyster Point Pharma, INC. | $49.81 | 2023-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $30.21 | 2023-2025 | Miebo, Biotrue One Day |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.52 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $19.24 | 2024 | Xdemvy |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Kala Pharmaceuticals, INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Tenorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.